<DOC>
	<DOCNO>NCT02270736</DOCNO>
	<brief_summary>The objective study investigate efficacy safety NT 201 compare placebo treatment chronic troublesome sialorrhea associate neurological disorder ( e.g . cerebral palsy , traumatic brain injury ) and/or intellectual disability child adolescent naïve Botulinum neurotoxin treatment age 2-17 year .</brief_summary>
	<brief_title>Clinical Study Investigate Efficacy Safety NT 201 Compared Placebo Treatment Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability</brief_title>
	<detailed_description />
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Cerebral Palsy</mesh_term>
	<mesh_term>Intellectual Disability</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Sialorrhea</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Male female child/adolescent age 217 year . Any neurological disorder ( e.g . cerebral palsy traumatic brain injury ) and/or intellectual disability associate chronic troublesome sialorrhea least 3 month screen . In subject intellectual disability ( ID ) without neurological disorder , diagnosis ID specialist , e.g . pediatrician center developmental medicine require inclusion . Severe drooling ( modify Teacher´s Drooling Scale [ mTDS ] ≥ 6 ; clothing occasionally become damp ) rat investigator . Parental consent subject 's oral write assent subject able provide . Chronic troublesome sialorrhea related neurological disorder and/or intellectual disability . Body weight &lt; 12 kg . Pharmacological treatment sialorrhea concomitant medication know influence sialorrhea strongly ( e.g . anticholinergic exception locally apply short act drug use general anesthesia ) within 45 day baseline entire study period . Any previous know suspected hypersensitivity Botulinum toxin . Aspiration pneumonia within 6 month screening . Any previous treatment Botulinum toxin body region year screen within screen period Prior , concomitant plan surgery irradiation head neck control sialorrhea ( include salivary gland surgery salivary gland irradiation ) within one year screening plan part entire study period . Concurrent disease , include hematological , hepatic , renal , gastrointestinal , endocrine , pulmonary , musculoskeletal , psychiatric disease condition , judgment investigator would put subject risk study , could influence result study , negatively impact subject 's ability participate study . Extremely poor dental and/or oral condition might preclude safe study participation judgment investigator . Nursing mother pregnant female subject .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>